Tag Archives: ondansetron

Ondansetron is the name for Zofran, an anti-nausea drug that is linked to serious birth defects. Contact our law office with more questions.

New Zofran (Ondansetron) Label Draws Ire of Families in MDL

Families involved in the Zofran (ondansetron) multidistrict litigation (“MDL”) alleged a 2016 label update for Zofran acknowledged for the first time that studies have shown an increased link between exposure to Zofran (ondansetron) and cardiovascular and cleft palate birth defects in babies born to women who took the drug while pregnant. However, the families contend...
Read more

Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

At the April 2016 Mass Torts Made Perfect conference in Las Vegas later this month, Grant & Eisenhofer Director Elizabeth Graham, co-lead on the Plaintiffs’ Executive Committee of the Zofran (ondansetron) multi-district litigation, will speak to the latest developments in the litigation. Ms. Graham will cover the status of the over 230 cases centralized...

Read more

Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL

In March 2016, with more than 200 lawsuits pending in the Zofran (ondansetron) federal multi-district litigation (“MDL”) in the District of Massachusetts, plaintiffs submitted their proposal on the sequence and effect of “Master Pleadings.” In a sequence of master pleadings, usually created for administrative reasons, master complaints collate claims brought in each case...

Read more

Zofran (ondansetron) MDL Continues to Grow

More and more parents are filing lawsuits against GlaxoSmithKline LLC (“GSK”), maker of anti-nausea drug Zofran (ondansetron), after their children exposed to the drug were born with birth defects. The drug, approved by the FDA to only treat nausea and vomiting in cancer patients undergoing chemotherapy and patients who had major surgeries, has been...

Read more

Real Time Analytics